This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| UK MS Register | |
|---|---|
| Name | UK MS Register |
| Established | 2011 |
| Type | Disease registry |
| Focus | Multiple sclerosis |
| Country | United Kingdom |
| Headquarters | Swansea |
UK MS Register
The UK MS Register is a national dataset collecting clinical, demographic and patient-reported information on people diagnosed with multiple sclerosis in the United Kingdom. It supports epidemiological surveillance, outcomes research and service planning by linking routine healthcare records with bespoke patient-reported outcomes and environmental data. The Register interfaces with clinical centres, academic institutions and charitable organisations to enable longitudinal analyses of disease course, treatment effects and quality of life.
The Register aggregates routinely collected data from National Health Service clinics, electronic health records, community treatment centres and bespoke online questionnaires to form a longitudinal cohort for multiple sclerosis. It aims to characterise incidence, prevalence and natural history across regions including England, Scotland, Wales and Northern Ireland, informing clinicians at specialist centres such as Salford Royal Hospital, academic units like University of Oxford and public bodies including Public Health Wales. Partner organisations include charities such as MS Society (United Kingdom) and research funders like Medical Research Council.
Conceived in the late 2000s amid growing interest in real-world evidence, the Register arose from collaborations between academic neurologists, health informaticians and patient groups. Early pilot work involved linkage with regional clinical datasets in centres including Swansea University and Cardiff University, followed by national roll-out supported by initiatives from bodies such as National Institute for Health and Care Research and policy forums like Health and Social Care Information Centre. Over successive funding rounds the platform expanded its technical infrastructure, incorporating secure data linkage methods developed in part by teams at University of Manchester and University of Edinburgh.
Governance is provided by a multi-stakeholder board comprising clinicians from specialist centres (for example Queen Elizabeth Hospital Birmingham), academics from institutions such as King's College London and patient representatives linked to charities like Multiple Sclerosis Trust. Funding streams have included competitive grants from public funders including Wellcome Trust, project contracts with health authorities such as NHS England and philanthropic support from organisations like Guy's and St Thomas' Charity. Ethical oversight is maintained via research ethics committees coordinated with bodies such as Health Research Authority and data governance aligns with standards promoted by UK Biobank-related frameworks.
Data sources encompass hospital episode statistics from providers including University Hospitals Birmingham NHS Foundation Trust, prescribing records from pharmacy services, imaging reports from radiology departments at centres like Royal Free Hospital and patient-reported outcome measures collected via online portals developed with partners such as Cardiff University. Environmental and lifestyle datasets have been linked using geographic units from ordnance surveys and public datasets maintained by Office for National Statistics, enabling analyses of factors including urban-rural residence and socio-demographic indices. Linkage techniques draw on pseudonymisation methods pioneered by health informatics groups at NHS Digital.
Analyses conducted using the Register have addressed treatment patterns, natural history and health-related quality of life, informing publications by research groups at University of Bristol, University of Glasgow and University College London. Studies have examined disease-modifying therapy uptake, relapse rates and transitions between clinical phenotypes, alongside comorbidity analyses involving conditions treated at specialised centres such as Royal Victoria Infirmary. Findings have been cited in systematic reviews alongside cohorts maintained by international consortia such as European MS Platform and comparative registries like MSBase.
Patient involvement has been central, with engagement forums run in partnership with advocacy groups including MS Society (United Kingdom) and Multiple Sclerosis Trust to co-design questionnaires and consent processes. Data access operates under controlled governance with application panels including lay members, following information governance principles promoted by ICO and ethical approval frameworks from Health Research Authority. Technical safeguards include secure servers located at research data centres affiliated with institutions such as Swansea University and accreditation processes used by clinical research networks like NIHR Clinical Research Network.
Evidence from the Register has informed clinical guideline development by organisations such as National Institute for Health and Care Excellence and service planning in regional bodies including Health Boards (Wales). Results have supported commissioning decisions about access to disease-modifying therapies and clinic provision, cited by policy units within NHS England and influencing audit programmes run with specialty groups like the Association of British Neurologists. The dataset continues to underpin research translation into practice across UK neurology services.
Category:Medical registries in the United Kingdom Category:Multiple sclerosis